Drug-induced immune thrombocytopenia: pathogenesis, diagnosis, and management
- 20 May 2009
- journal article
- review article
- Published by Elsevier BV in Journal of Thrombosis and Haemostasis
- Vol. 7 (6), 911-918
- https://doi.org/10.1111/j.1538-7836.2009.03360.x
Abstract
No abstract availableThis publication has 90 references indexed in Scilit:
- Quinine-dependent, platelet-reactive monoclonals mimic antibodies found in patients with quinine-induced immune thrombocytopeniaBlood, 2009
- Drug-Induced ThrombocytopeniaDrug Safety, 2009
- Fine specificity of drug-dependent antibodies reactive with a restricted domain of platelet GPIIIABlood, 2008
- Drug-Induced Immune ThrombocytopeniaThe New England Journal of Medicine, 2007
- Patients with quinine-induced immune thrombocytopenia have both “drug-dependent” and “drug-specific” antibodiesBlood, 2006
- Final results of the ReoPro readministration registryThe American Journal of Cardiology, 2004
- Drug-induced thrombocytopenia: localization of the binding site of GPIX-specific quinine-dependent antibodiesBlood, 2003
- Binding of quinine- and quinidine-dependent drug antibodies to platelets is mediated by the Fab domain of the immunoglobulin G and is not Fc dependent.JCI Insight, 1987
- Fab-mediated binding of drug-dependent antibodies to platelets in quinidine- and quinine-induced thrombocytopenia.JCI Insight, 1985
- Thrombocytopenic purpura due to Lupinus termis beanJournal of Allergy, 1964